Certain Bone Cements, Components Thereof and Products Containing the Same; Commission Determination Not To Review an Initial Determination Granting Complainants' Renewed Motion for Leave To Amend the First Amended Complaint and Notice of Investigation, 35884-35885 [2019-15760]

Download as PDF 35884 Federal Register / Vol. 84, No. 143 / Thursday, July 25, 2019 / Notices Issued: July 22, 2019. William Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2019–15801 Filed 7–24–19; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation Nos. 701–TA–626 and 731– TA–1452–1454 (Preliminary)] Certain Collated Steel Staples From China, Korea, and Taiwan; Determinations On the basis of the record 1 developed in the subject investigations, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that there is a reasonable indication that an industry in the United States is materially injured by reason of imports of certain collated steel staples (‘‘CCS staples’’) from China, provided for in subheading 8305.20.00 of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than fair value (‘‘LTFV’’) and to be subsidized by the government of China.2 3 The Commission further determines that imports of CCS staples from Korea and Taiwan that are alleged to be sold in the United States at LTFV are negligible pursuant to section 771(24) of the Act, and its antidumping duty investigations with regard to CCS staples from Korea and Taiwan are thereby terminated pursuant to section 703(a)(1) of the Act. Commencement of Final Phase Investigations Pursuant to section 207.18 of the Commission’s rules, the Commission also gives notice of the commencement of the final phase of its investigations with respect to imports of CCS staples from China. The Commission will issue a final phase notice of scheduling, which will be published in the Federal Register as provided in section 207.21 of the Commission’s rules, upon notice from the U.S. Department of Commerce (‘‘Commerce’’) of affirmative preliminary determinations in the jspears on DSK30JT082PROD with NOTICES 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). 2 Certain Collated Steel Staples From the People’s Republic of China: Initiation of Countervailing Duty Investigation, 84 FR 31840, July 3, 2019. Certain Collated Steel Staples From the People’s Republic of China, the Republic of Korea, and Taiwan: Initiation of Less-Than-Fair-Value Investigations, 84 FR 31833, July 3, 2019. 3 Commissioner Jason E. Kearns did not participate in these investigations. VerDate Sep<11>2014 16:56 Jul 24, 2019 Jkt 247001 investigations under sections 703(b) or 733(b) of the Act, or, if the preliminary determinations are negative, upon notice of affirmative final determinations in those investigations under sections 705(a) or 735(a) of the Act. Any parties that filed entries of appearance in the preliminary phase of the investigations need not enter a separate appearance for the final phase of the investigations. Industrial users, and, if the merchandise under investigation is sold at the retail level, representative consumer organizations have the right to appear as parties in Commission antidumping and countervailing duty investigations. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives, who are parties to the investigations. Background On June 6, 2019, Kyocera Senco Industrial Tools, Inc. (‘‘Senco’’), Cincinnati, Ohio, filed petitions with the Commission and Commerce, alleging that an industry in the United States is materially injured or threatened with material injury by reason of subsidized imports of CCS staples from China and LTFV imports of CCS staples from China, Korea, and Taiwan. Accordingly, effective June 6, 2019, the Commission, pursuant to sections 703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)), instituted countervailing duty investigation No. 701–TA–626 and antidumping duty investigation Nos. 731–TA–1452–1454 (Preliminary). Notice of the institution of the Commission’s investigations and of a public conference to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of June 14, 2019 (84 FR 27803). The conference was held in Washington, DC, on June 27, 2019, and all persons who requested the opportunity were permitted to appear in person or by counsel. The Commission made these determinations pursuant to sections 703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)). It completed and filed its determinations in these investigations on July 22, 2019. The views of the Commission are contained in USITC Publication 4939 (July 2019), entitled Certain Collated Steel Staples from China, Korea, and Taiwan: Investigation Nos. 701–TA–626 and 731–TA–1452–1454 (Preliminary). PO 00000 By order of the Commission. Frm 00036 Fmt 4703 Sfmt 4703 Issued: July 22, 2019. William Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2019–15830 Filed 7–24–19; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [USITC SE–19–028] Sunshine Act Meetings United States International Trade Commission. TIME AND DATE: July 30, 2019 at 9:30 a.m. PLACE: Room 101, 500 E Street SW, Washington, DC 20436. Telephone: (202) 205–2000. STATUS: Open to the public. MATTERS TO BE CONSIDERED: 1. Agendas for future meetings: None. 2. Minutes. 3. Ratification List. 4. Vote on Inv. Nos. 701–TA–405–406 and 408 and 731–TA–899–901 and 906– 908 (Third Review) (Hot-Rolled Carbon Steel Flat Products from China, India, Indonesia, Taiwan, Thailand, and Ukraine). The Commission is currently scheduled to complete and file its determinations and views of the Commission by August 13, 2019. 5. Outstanding action jackets: None. The Commission is holding the meeting under the Government in the Sunshine Act, 5 U.S.C. 552(b). In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. AGENCY HOLDING THE MEETING: By order of the Commission. Issued: July 22, 2019. William Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2019–15881 Filed 7–23–19; 11:15 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1153] Certain Bone Cements, Components Thereof and Products Containing the Same; Commission Determination Not To Review an Initial Determination Granting Complainants’ Renewed Motion for Leave To Amend the First Amended Complaint and Notice of Investigation U.S. International Trade Commission. AGENCY: E:\FR\FM\25JYN1.SGM 25JYN1 Federal Register / Vol. 84, No. 143 / Thursday, July 25, 2019 / Notices ACTION: Notice. Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 18) of the presiding Administrative Law Judge (‘‘ALJ’’) granting complainants’ renewed motion for leave to amend the first amended complaint and notice of investigation. FOR FURTHER INFORMATION CONTACT: Michael Liberman, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–3115. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on April 10, 2019, based on a complaint filed by Heraeus Medical LLC of Yardley, Pennsylvania, and Heraeus Medical GmbH of Wehrheim, Germany (collectively, ‘‘Heraeus’’). 84 FR 14394– 95 (Apr. 10, 2019). The complaint alleges a violation of section 337 by reason of misappropriation of trade secrets, the threat or effect of which is to destroy or substantially injure a domestic industry in the United States or to prevent the establishment of such an industry. The complaint named as respondents Zimmer Biomet Holdings, Inc. of Warsaw, Indiana; Biomet, Inc. of Warsaw, Indiana; Zimmer Orthopaedic Surgical Products, Inc. of Dover, Ohio; Zimmer Surgical, Inc. of Dover, Ohio; Biomet France S.A.R.L. of Valence, France; Biomet Deutschland GmbH of Berlin, Germany; Zimmer Biomet Deutschland GmbH of Freiburg im Breisgau, Germany; Biomet Europe B.V. of Dordrecht, Netherlands; Biomet Global Supply Chain Center B.V. of Dordrecht, Netherlands; Zimmer Biomet Nederland B.V. of Dordrecht, Netherlands; Biomet Orthopedics, LLC of Warsaw, Indiana; and Biomet Orthopaedics Switzerland GmbH of jspears on DSK30JT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:56 Jul 24, 2019 Jkt 247001 Dietikon, Switzerland. The Commission’s Office of Unfair Import Investigations (‘‘OUII’’) was named as a party. Subsequently, the investigation was terminated as to respondents Zimmer Orthopaedic Surgical Products, Inc. and Biomet Europe B.V. Order No. 10 (May 23, 2019), unreviewed Notice (June 14, 2019). On June 17, 2019, complainants Heraeus moved for leave to amend the first amended complaint and notice of investigation to add three entities as respondents: Zimmer US, Inc. of Warsaw, Indiana; Zimmer, GmbH of Winterthur, Switzerland; and Biomet Manufacturing, LLC of Warsaw, Indiana. On June 21, 2019, respondents Zimmer Biomet Holdings, Inc.; Biomet, Inc.; Zimmer Surgical, Inc.; Biomet France S.A.R.L.; Biomet Deutschland GmbH; Zimmer Biomet Deutschland GmbH; Biomet Global Supply Chain Center B.V.; Zimmer Biomet Nederland B.V.; Biomet Orthopedics, LLC; and Biomet Orthopaedics Switzerland GmbH (collectively, ‘‘Biomet’’) filed a response not opposing the motion to add the three entities. On June 25, 2019, OUII also filed a response supporting the motion. On June 26, 2019, the ALJ issued the subject ID Commission Rule 210.14(b)(1) (19 CFR 210.14(b)(1)), granting the motion. The ALJ found that respondents’ motion complies with the Commission’s rules. ID at 2. The ALJ also found that there is no dispute over Heraeus’s claim that it did not know nor should have known of the three entities’ roles in the sale for importation, importation, and/or sale after importation of the accused products in this investigation prior to Biomet’s discovery responses. Id. at 2–3. The ALJ found that such a circumstance constitutes the requisite good cause. Id. at 3. The ALJ further found that the certificate of service appended to Heraeus’s motion indicates the three entities were served with the motion in accordance with Commission Rule 210.14(b) (19 CFR 210.14(b)). Id. (citing Mot. Mem. at 12.) The ALJ also found no prejudice to the public interest or to the rights of the parties to the investigation would result from granting the motion. Id. No party petitioned for review of the ID. The Commission has determined not to review the subject ID. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, and in Part 210 of the Commission’s Rules of Practice and Procedure, 19 CFR part 210. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 35885 By order of the Commission. Issued: July 19, 2019. Lisa Barton, Secretary to the Commission. [FR Doc. 2019–15760 Filed 7–24–19; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE [OMB Number 1103–NEW] Agency Information Collection Activities: New Information Collection Instrument ACTION: 30-Day notice. The Department of Justice (DOJ) Office of Community Oriented Policing Services (COPS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: The purpose of this notice is to allow for 30 days for public comment August 26, 2019. FOR FURTHER INFORMATION CONTACT: If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Lashon M. Hilliard, Department of Justice Office of Community Oriented Policing Services, 145 N Street NE, Washington, DC 20530, (202) 514–6563. Written comments and/or suggestions can also be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20530 or sent to OIRA_submissions@omb.eop.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used —Enhance the quality, utility, and clarity of the information to be collected; and SUMMARY: E:\FR\FM\25JYN1.SGM 25JYN1

Agencies

[Federal Register Volume 84, Number 143 (Thursday, July 25, 2019)]
[Notices]
[Pages 35884-35885]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15760]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1153]


Certain Bone Cements, Components Thereof and Products Containing 
the Same; Commission Determination Not To Review an Initial 
Determination Granting Complainants' Renewed Motion for Leave To Amend 
the First Amended Complaint and Notice of Investigation

AGENCY: U.S. International Trade Commission.

[[Page 35885]]


ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review an initial determination 
(``ID'') (Order No. 18) of the presiding Administrative Law Judge 
(``ALJ'') granting complainants' renewed motion for leave to amend the 
first amended complaint and notice of investigation.

FOR FURTHER INFORMATION CONTACT: Michael Liberman, Esq., Office of the 
General Counsel, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone (202) 205-3115. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW, Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on April 10, 2019, based on a complaint filed by Heraeus Medical LLC of 
Yardley, Pennsylvania, and Heraeus Medical GmbH of Wehrheim, Germany 
(collectively, ``Heraeus''). 84 FR 14394-95 (Apr. 10, 2019). The 
complaint alleges a violation of section 337 by reason of 
misappropriation of trade secrets, the threat or effect of which is to 
destroy or substantially injure a domestic industry in the United 
States or to prevent the establishment of such an industry. The 
complaint named as respondents Zimmer Biomet Holdings, Inc. of Warsaw, 
Indiana; Biomet, Inc. of Warsaw, Indiana; Zimmer Orthopaedic Surgical 
Products, Inc. of Dover, Ohio; Zimmer Surgical, Inc. of Dover, Ohio; 
Biomet France S.A.R.L. of Valence, France; Biomet Deutschland GmbH of 
Berlin, Germany; Zimmer Biomet Deutschland GmbH of Freiburg im 
Breisgau, Germany; Biomet Europe B.V. of Dordrecht, Netherlands; Biomet 
Global Supply Chain Center B.V. of Dordrecht, Netherlands; Zimmer 
Biomet Nederland B.V. of Dordrecht, Netherlands; Biomet Orthopedics, 
LLC of Warsaw, Indiana; and Biomet Orthopaedics Switzerland GmbH of 
Dietikon, Switzerland. The Commission's Office of Unfair Import 
Investigations (``OUII'') was named as a party. Subsequently, the 
investigation was terminated as to respondents Zimmer Orthopaedic 
Surgical Products, Inc. and Biomet Europe B.V. Order No. 10 (May 23, 
2019), unreviewed Notice (June 14, 2019).
    On June 17, 2019, complainants Heraeus moved for leave to amend the 
first amended complaint and notice of investigation to add three 
entities as respondents: Zimmer US, Inc. of Warsaw, Indiana; Zimmer, 
GmbH of Winterthur, Switzerland; and Biomet Manufacturing, LLC of 
Warsaw, Indiana. On June 21, 2019, respondents Zimmer Biomet Holdings, 
Inc.; Biomet, Inc.; Zimmer Surgical, Inc.; Biomet France S.A.R.L.; 
Biomet Deutschland GmbH; Zimmer Biomet Deutschland GmbH; Biomet Global 
Supply Chain Center B.V.; Zimmer Biomet Nederland B.V.; Biomet 
Orthopedics, LLC; and Biomet Orthopaedics Switzerland GmbH 
(collectively, ``Biomet'') filed a response not opposing the motion to 
add the three entities. On June 25, 2019, OUII also filed a response 
supporting the motion.
    On June 26, 2019, the ALJ issued the subject ID Commission Rule 
210.14(b)(1) (19 CFR 210.14(b)(1)), granting the motion. The ALJ found 
that respondents' motion complies with the Commission's rules. ID at 2. 
The ALJ also found that there is no dispute over Heraeus's claim that 
it did not know nor should have known of the three entities' roles in 
the sale for importation, importation, and/or sale after importation of 
the accused products in this investigation prior to Biomet's discovery 
responses. Id. at 2-3. The ALJ found that such a circumstance 
constitutes the requisite good cause. Id. at 3. The ALJ further found 
that the certificate of service appended to Heraeus's motion indicates 
the three entities were served with the motion in accordance with 
Commission Rule 210.14(b) (19 CFR 210.14(b)). Id. (citing Mot. Mem. at 
12.) The ALJ also found no prejudice to the public interest or to the 
rights of the parties to the investigation would result from granting 
the motion. Id. No party petitioned for review of the ID.
    The Commission has determined not to review the subject ID.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, and 
in Part 210 of the Commission's Rules of Practice and Procedure, 19 CFR 
part 210.

    By order of the Commission.

    Issued: July 19, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019-15760 Filed 7-24-19; 8:45 am]
 BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.